Logo
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Tue 21 July 2026
Logo
  • Drug Discovery and Development
    • Drug Discovery
    • IND
    • Phase 1-2 trials
    • Phase 3 trials
    • Approvals
  • Finance
  • Conferences
  • Journal
    • Drug DiscoveryINDPhase 1-2 trialsPhase 3 trialsApprovals

      Orexo announces positive outcome from in vivo study of OX390

      19 June 2026

      MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours

      19 June 2026

      Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a study in patients with pancreatic cancer

      19 June 2026

      Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma

      19 June 2026

      New clinical study shows pasteurised Akkermansia muciniphila MucT supports weight loss maintenance

      19 June 2026
  • Products
  • CDMO
  • CRO

Log In

Don't have an account? Sign up
Logo

Drug Discovery & Development (DDD) is dedicated to advancing scientific innovations into active medical solutions. Its aim is to accelerate breakthroughs in medicine, addressing human disease and improving global health outcomes.

Menu

  • Drug Discovery and Development
  • Finance
  • Conferences
  • Journal
  • Products
  • CDMO
  • CRO

© Web design by Social Media Services 2026. All rights reserved.

  • About us
  • Advertise / Partner
  • Contact
  • Editorial standards
  • Terms and conditions
Linkedin
Twitter
Youtube
Facebook